JING NING

TitleAssociate Professor
InstitutionMD Anderson
DepartmentBiostatistics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Short NJ, Borthakur G, Pemmaraju N, Dinardo CD, Kadia TM, Jabbour E, Konopleva M, Macaron W, Ning J, Ma J, Pierce S, Alvarado Y, Sasaki K, Takahashi K, Estrov Z, Masarova L, Issa GC, Montalban-Bravo G, Andreeff M, Burger JA, Miller D, Alexander L, Naing A, Garcia-Manero G, Ravandi F, Daver N. A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia. Leuk Lymphoma. 2022 Apr 20; 1-10. PMID: 35442137.
      Citations:    Fields:    
    2. Wang W, He Y, Zhai LL, Chen LJ, Yao LC, Wu L, Tang ZG, Ning JZ. m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Epigenetics. 2022 Apr 11; 1-15. PMID: 35404184.
      Citations:    Fields:    
    3. Kanwal F, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Amos CI, Thrift AP, Gu X, Luster M, Al-Sarraj A, Ning J, El-Serag HB. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2022 Mar 01. PMID: 35229329.
      Citations:    Fields:    
    4. Ning J, Pak D, Zhu H, Qin J. Conditional Independence Test of Failure and Truncation Times: Essential Tool for Method Selection. Comput Stat Data Anal. 2022 Apr; 168. PMID: 34898770.
      Citations:    
    5. Wang J, Ning J, Shete S. Mediation model with a categorical exposure and a censored mediator with application to a genetic study. PLoS One. 2021; 16(10):e0257628. PMID: 34637449.
      Citations: 1     Fields:    Translation:Humans
    6. Issa GC, Zarka J, Sasaki K, Qiao W, Pak D, Ning J, Short NJ, Haddad F, Tang Z, Patel KP, Cuglievan B, Daver N, DiNardo CD, Jabbour E, Kadia T, Borthakur G, Garcia-Manero G, Konopleva M, Andreeff M, Kantarjian HM, Ravandi F. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood Cancer J. 2021 09 29; 11(9):162. PMID: 34588432.
      Citations: 2     Fields:    Translation:Humans
    7. Ning JZ, Chu CM, Du Y, Zuo L. MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma. J Cancer. 2021; 12(22):6706-6714. PMID: 34659560.
      Citations:    
    8. Venugopal S, Maiti A, DiNardo CD, Qiao W, Ning J, Loghavi S, Daver NG, Kadia TM, Rausch CR, Alvarado Y, Ohanian M, Sasaki K, Short NJ, Takahashi K, Yilmaz M, Ravandi F, Kantarjian HM, Konopleva MY. Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Leuk Lymphoma. 2021 12; 62(14):3501-3505. PMID: 34474640.
      Citations:    Fields:    Translation:Humans
    9. Maiti A, DiNardo CD, Qiao W, Kadia TM, Jabbour EJ, Rausch CR, Daver NG, Short NJ, Borthakur G, Pemmaraju N, Yilmaz M, Alvarado Y, Montalbano KS, Wade A, Maduike RE, Guerrero JA, Vaughan K, Bivins CA, Pierce S, Ning J, Ravandi F, Kantarjian HM, Konopleva MY. Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis. Cancer. 2021 11 15; 127(22):4213-4220. PMID: 34343352.
      Citations: 4     Fields:    Translation:Humans
    10. Wang J, Ma J, Cai C, Daver N, Ning J. A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules. Stat Med. 2021 09 20; 40(21):4629-4639. PMID: 34101217.
      Citations:    Fields:    Translation:Humans
    11. Jain N, Maiti A, Ravandi F, Konopleva M, Daver N, Kadia T, Pemmaraju N, Short N, Kebriaei P, Ning J, Cortes J, Jabbour E, Kantarjian H. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. Am J Hematol. 2021 08 01; 96(8):1000-1007. PMID: 33991360.
      Citations: 2     Fields:    Translation:HumansCells
    12. El-Hadad C, Rubin ML, Nagarajan P, Ford JR, Xu S, Ning J, Esmaeli B. Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma. Ophthalmic Plast Reconstr Surg. 2021 May-Jun 01; 37(3):262-268. PMID: 33009325.
      Citations: 1     Fields:    Translation:Humans
    13. Rausch CR, DiNardo CD, Maiti A, Jammal NJ, Kadia TM, Marx KR, Borthakur G, Savoy JM, Pemmaraju N, DiPippo AJ, Daver NG, Chew SM, Sasaki K, Issa GC, Short NJ, Takahashi K, Ohanian MN, Ning J, Xiao L, Alvarado Y, Kontoyiannis DP, Ravandi F, Kantarjian HM, Konopleva MY. Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Cancer. 2021 07 15; 127(14):2489-2499. PMID: 33793970.
      Citations: 4     Fields:    Translation:Humans
    14. Dalle IA, Paranal R, Zarka J, Paul S, Sasaki K, Li W, Ning J, Short NJ, Ohanian M, Cortes JE, Jabbour EJ, Issa GC. Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia. Haematologica. 2021 04 01; 106(4):1097-1105. PMID: 33297667.
      Citations: 3     Fields:    Translation:HumansAnimals
    15. Smith DL, Debeb BG, Diagaradjane P, Larson R, Kumar S, Ning J, Lacerda L, Li L, Woodward WA. Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer. Genes Cancer. 2021; 12:28-38. PMID: 33884104.
      Citations: 1     
    16. Maiti A, Rausch CR, Cortes JE, Pemmaraju N, Daver NG, Ravandi F, Garcia-Manero G, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Kadia TM, Takahashi K, Yilmaz M, Jain N, Kornblau S, Montalban Bravo G, Sasaki K, Andreeff M, Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang S, Konoplev S, Pierce SA, Ning J, Qiao W, Welch JS, Kantarjian HM, DiNardo CD, Konopleva MY. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens. Haematologica. 2021 03 01; 106(3):894-898. PMID: 32499238.
      Citations: 13     Fields:    Translation:Humans
    17. Li W, Song YY, Rao T, Yu WM, Ruan Y, Ning JZ, Yao XB, Yang SY, Cheng F. CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma. J Cell Mol Med. 2022 03; 26(6):1729-1741. PMID: 33560588.
      Citations: 6     Fields:    Translation:HumansCells
    18. Maiti A, Qiao W, Sasaki K, Ravandi F, Kadia TM, Jabbour EJ, Daver NG, Borthakur G, Garcia-Manero G, Pierce SA, Montalbano KS, Pemmaraju N, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Takahashi K, Yilmaz M, Jain N, Kornblau SM, Andreeff M, Bose P, Ferrajoli A, Issa GC, Masarova L, Thompson PA, Rausch CR, Ning J, Kantarjian HM, DiNardo CD, Konopleva MY. Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. Am J Hematol. 2021 03 01; 96(3):282-291. PMID: 33264443.
      Citations: 15     Fields:    Translation:Humans
    19. Diao S, Nichols ED, DiNardo C, Konopleva M, Ning J, Qiao W, Maiti A, DiPippo AJ. Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax. Am J Hematol. 2021 03 01; 96(3):E65-E68. PMID: 33259075.
      Citations: 1     Fields:    Translation:Humans
    20. DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Lancet Haematol. 2020 Oct; 7(10):e724-e736. PMID: 32896301.
      Citations: 62     Fields:    Translation:HumansCTClinical Trials
    21. Wang W, Ning JZ, Tang ZG, He Y, Yao LC, Ye L, Wu L. MicroRNA-23a acts as an oncogene in pancreatic carcinoma by targeting TFPI-2. Exp Ther Med. 2020 Nov; 20(5):53. PMID: 32952643.
      Citations: 1     
    22. Issa GC, Kantarjian HM, Xiao L, Ning J, Alvarado Y, Borthakur G, Daver N, DiNardo CD, Jabbour E, Bose P, Jain N, Kadia TM, Naqvi K, Pemmaraju N, Takahashi K, Verstovsek S, Andreeff M, Kornblau SM, Estrov Z, Ferrajoli A, Garcia-Manero G, Ohanian M, Wierda WG, Ravandi F, Cortes JE. Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia. 2020 11; 34(11):2914-2924. PMID: 32546726.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    23. Blessing AM, Santiago-O'Farrill JM, Mao W, Pang L, Ning J, Pak D, Bollu LR, Rask P, Iles L, Yang H, Tran S, Elmir E, Bartholomeusz G, Langley R, Lu Z, Bast RC. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition. Cancer. 2020 08 01; 126(15):3579-3592. PMID: 32484926.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    24. Xia F, George SL, Ning J, Li L, Huang X. A Signature Enrichment Design with Bayesian Adaptive Randomization. J Appl Stat. 2021; 48(6):1091-1110. PMID: 34024982.
      Citations: 1     
    25. Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol. 2020 11; 140(11):2146-2156.e4. PMID: 32304704.
      Citations: 5     Fields:    Translation:HumansCells
    26. Sa HS, Rubin ML, Ning J, Li W, Tetzlaff MT, McGovern SL, Paulino AC, Herzog CE, Gill JB, Esmaeli B. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381. PMID: 32105303.
      Citations: 1     Fields:    Translation:Humans
    27. Ning JZ, Yu WM, Cheng F, Rao T, Ruan Y. MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3. J Cancer. 2020; 11(12):3424-3432. PMID: 32284738.
      Citations: 2     
    28. Ning J, Cai C, Chen Y, Huang X, Wang MC. Semiparametric modelling and estimation of covariate-adjusted dependence between bivariate recurrent events. Biometrics. 2020 12; 76(4):1229-1239. PMID: 31994170.
      Citations:    Fields:    Translation:Humans
    29. Xu S, Moss TJ, Laura Rubin M, Ning J, Eterovic K, Yu H, Jia R, Fan X, Tetzlaff MT, Esmaeli B. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis. Mod Pathol. 2020 07; 33(7):1256-1263. PMID: 31937901.
      Citations: 4     Fields:    Translation:Humans
    30. Yang WL, Lu Z, Guo J, Fellman BM, Ning J, Lu KH, Menon U, Kobayashi M, Hanash SM, Celestino J, Skates SJ, Bast RC. Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer. Cancer. 2020 02 15; 126(4):725-736. PMID: 31714597.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    31. Qiao W, Ning J, Huang X. A clinical trial design with covariate-adjusted response-adaptive randomization using superiority confidence of treatments. Stat Biopharm Res. 2019; 11(4):336-347. PMID: 34113421.
      Citations:    
    32. Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J, Fuller CD, Li H, Howell RM, Layman RR, Mawlawi O, Stafford RJ, Aerts H, Court LE. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients. PLoS One. 2019; 14(9):e0222509. PMID: 31536526.
      Citations: 17     Fields:    Translation:Humans
    33. Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 2020 Feb; 476(2):295-305. PMID: 31423558.
      Citations: 7     Fields:    Translation:Humans
    34. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513. PMID: 31383963.
      Citations: 4     Fields:    Translation:Humans
    35. Ning J, Fouad TM, Lin H, Sahin AA, Lucci A, Woodward WA, Krishnamurthy S, Tripathy D, Ueno NT, Shen Y. The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer. J Cancer. 2019; 10(12):2635-2642. PMID: 31258771.
      Citations:    
    36. Nagarajan P, El-Hadad C, Gruschkus SK, Ning J, Hudgens CW, Sagiv O, Gross N, Tetzlaff MT, Esmaeli B. PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma. Invest Ophthalmol Vis Sci. 2019 05 01; 60(6):2388-2398. PMID: 31141610.
      Citations: 7     Fields:    Translation:HumansCells
    37. Xu S, Sagiv O, Rubin ML, Sa HS, Tetzlaff MT, Nagarajan P, Ning J, Esmaeli B. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma. JAMA Ophthalmol. 2019 05 01; 137(5):537-542. PMID: 30869769.
      Citations: 3     Fields:    Translation:Humans
    38. Curry JL, Reuben A, Szczepaniak-Sloane R, Ning J, Milton DR, Lee CH, Hudgens C, George S, Torres-Cabala C, Johnson D, Subramanya S, Wargo JA, Mudaliar K, Wistuba II, Prieto VG, Diab A, Tetzlaff MT. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol. 2019 Sep; 46(9):627-636. PMID: 30883858.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    39. Yuan Y, Qiu J, Lin ZT, Li W, Haley C, Mui UN, Ning J, Tyring SK, Wu T. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheumatol. 2019 06; 71(6):941-951. PMID: 30618213.
      Citations: 17     Fields:    Translation:Humans
    40. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB. Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. Am J Gastroenterol. 2019 03; 114(3):530-532. PMID: 30699099.
      Citations: 11     Fields:    Translation:Humans
    41. Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang AG, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clin Cancer Res. 2019 06 01; 25(11):3455-3467. PMID: 30808776.
      Citations: 9     Fields:    Translation:HumansCells
    42. Huang X, Liu L, Ning J, Li L, Shen Y. Estimation of the distribution of longitudinal biomarker trajectories prior to disease progression. Stat Med. 2019 05 20; 38(11):2030-2046. PMID: 30614014.
      Citations: 1     Fields:    Translation:Humans
    43. Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, Flores W, Bueso-Ramos C, Blando J, Galera P, Calvo KR, Al-Atrash G, Allison JP, Kantarjian HM, Sharma P, Daver NG. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019 05 01; 125(9):1470-1481. PMID: 30500073.
      Citations: 84     Fields:    Translation:HumansCells
    44. Short NJ, Jabbour E, Naqvi K, Patel A, Ning J, Sasaki K, Nogueras-Gonzalez GM, Bose P, Kornblau SM, Takahashi K, Andreeff M, Sanchez-Petitto G, Estrov Z, Dinardo CD, Montalban-Bravo G, Konopleva M, Alvarado Y, Bhalla KN, Fiskus W, Khouri M, Islam R, Kantarjian H, Garcia-Manero G. A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Am J Hematol. 2019 01; 94(1):74-79. PMID: 30328139.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    45. Wang J, Ning J, Shete S. Mediation analysis in a case-control study when the mediator is a censored variable. Stat Med. 2019 03 30; 38(7):1213-1229. PMID: 30421436.
      Citations: 2     Fields:    Translation:Humans
    46. Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res. 2019 02 15; 25(4):1280-1290. PMID: 30420449.
      Citations: 7     Fields:    Translation:HumansCells
    47. Daver N, Garcia-Manero G, Basu S, Boddu PC, Alfayez M, Cortes JE, Konopleva M, Ravandi-Kashani F, Jabbour E, Kadia T, Nogueras-Gonzalez GM, Ning J, Pemmaraju N, DiNardo CD, Andreeff M, Pierce SA, Gordon T, Kornblau SM, Flores W, Alhamal Z, Bueso-Ramos C, Jorgensen JL, Patel KP, Blando J, Allison JP, Sharma P, Kantarjian H. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study. Cancer Discov. 2019 03; 9(3):370-383. PMID: 30409776.
      Citations: 151     Fields:    Translation:HumansCTClinical Trials
    48. Jayaprakash P, Ai M, Liu A, Budhani P, Bartkowiak T, Sheng J, Ager C, Nicholas C, Jaiswal AR, Sun Y, Shah K, Balasubramanyam S, Li N, Wang G, Ning J, Zal A, Zal T, Curran MA. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J Clin Invest. 2018 11 01; 128(11):5137-5149. PMID: 30188869.
      Citations: 125     Fields:    Translation:AnimalsCells
    49. Benton CB, Khan M, Sallman D, Nazha A, Nogueras González GM, Piao J, Ning J, Aung F, Al Ali N, Jabbour E, Kadia TM, Borthakur G, Ravandi F, Pierce S, Steensma D, DeZern A, Roboz G, Sekeres M, Andreeff M, Kantarjian H, Komrokji RS, Garcia-Manero G. Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R. Am J Hematol. 2018 10; 93(10):1245-1253. PMID: 30051599.
      Citations: 14     Fields:    Translation:HumansCells
    50. Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, Kandl TJ, Esmaeli B. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2019 07; 103(7):980-984. PMID: 30131380.
      Citations: 11     Fields:    Translation:Humans
    51. Du D, Yuan J, Ma W, Ning J, Weinstein JN, Yuan X, Fuller GN, Liu Y. Clinical significance of FBXO17 gene expression in high-grade glioma. BMC Cancer. 2018 Jul 31; 18(1):773. PMID: 30064493.
      Citations: 5     Fields:    Translation:HumansCells
    52. Kandl TJ, Sagiv O, Curry JL, Ning J, Ma J, Hudgens CW, Van Arnam J, Wargo JA, Esmaeli B, Tetzlaff MT. High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. Oncoimmunology. 2018; 7(9):e1475874. PMID: 30228943.
      Citations: 4     Fields:    
    53. Khan M, Loree JM, Advani SM, Ning J, Li W, Pereira AAL, Lam M, Raghav K, Morris VK, Broaddus R, Maru D, Overman MJ, Kopetz S. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics. Clin Colorectal Cancer. 2018 12; 17(4):e699-e709. PMID: 30205948.
      Citations: 21     Fields:    Translation:HumansCells
    54. Li L, Wu CH, Ning J, Huang X, Tina Shih YC, Shen Y. Semiparametric Estimation of Longitudinal Medical Cost Trajectory. J Am Stat Assoc. 2018; 113(522):582-592. PMID: 30853736.
      Citations: 3     
    55. Xia F, Ning J, Huang X. Empirical Comparison of the Breslow Estimator and the Kalbfleisch Prentice Estimator for Survival Functions. J Biom Biostat. 2018; 9(2). PMID: 30370174.
      Citations: 2     
    56. Lee CH, Ning J, Shen Y. Model diagnostics for the proportional hazards model with length-biased data. Lifetime Data Anal. 2019 01; 25(1):79-96. PMID: 29450809.
      Citations: 1     Fields:    Translation:Humans
    57. Hu W, Shi L, Li MY, Zhou PH, Qiu B, Yin K, Zhang HH, Gao Y, Kang R, Qin SL, Ning JZ, Wang W, Zhang LJ. Adrenomedullin protects Leydig cells against lipopolysaccharide-induced oxidative stress and inflammatory reaction via MAPK/NF-?B signalling pathways. Sci Rep. 2017 11 28; 7(1):16479. PMID: 29184072.
      Citations: 9     Fields:    Translation:AnimalsCells
    58. Dahlstrom KR, Anderson KS, Field MS, Chowell D, Ning J, Li N, Wei Q, Li G, Sturgis EM. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15; 123(24):4886-4894. PMID: 28898394.
      Citations: 7     Fields:    Translation:HumansCells
    59. Lee CH, Ning J, Shen Y. Analysis of restricted mean survival time for length-biased data. Biometrics. 2018 06; 74(2):575-583. PMID: 28886217.
      Citations: 2     Fields:    
    60. Thuro BA, Ning J, Peng SA, Pace ST, Dudeja G, Ozgur O, Turturro F, Samaniego F, Hagemeister FB, Fayad LE, Fowler NH, Pinnix CC, Debnam JM, Esmaeli B. Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma. Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct; 33(5):355-360. PMID: 27636243.
      Citations: 3     Fields:    Translation:Humans
    61. Ning J, Chen Y, Piao J. Maximum likelihood estimation and EM algorithm of Copas-like selection model for publication bias correction. Biostatistics. 2017 Jul 01; 18(3):495-504. PMID: 28334132.
      Citations: 2     Fields:    Translation:Humans
    62. Ning J, Hong C, Li L, Huang X, Shen Y. Estimating treatment effects in observational studies with both prevalent and incident cohorts. Can J Stat. 2017 Jun; 45(2):202-219. PMID: 29056817.
      Citations: 1     
    63. Du Y, Liu XH, Zhu HC, Wang L, Ning JZ, Xiao CC. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP. Cell Physiol Biochem. 2017; 41(3):1135-1146. PMID: 28245474.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    64. Arora K, Kelley J, Sui D, Ning J, Martinez F, Lichtiger B, Tholpady A. Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions. Transfusion. 2017 04; 57(4):952-958. PMID: 28191636.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    65. Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MT. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104. PMID: 27864417.
      Citations: 13     Fields:    Translation:Humans
    66. Zhou R, Zhu H, Bondy M, Ning J. Analyzing semi-competing risks data with missing cause of informative terminal event. Stat Med. 2017 02 28; 36(5):738-753. PMID: 27813148.
      Citations:    Fields:    Translation:Humans
    67. Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, Thakar S, Thuro B, Prieto VG, Ross MI, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol. 2017 Jun; 95(4):e323-e328. PMID: 27775232.
      Citations: 8     Fields:    Translation:Humans
    68. Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R. Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up. Ann Surg Oncol. 2017 Jan; 24(1):187-193. PMID: 27660258.
      Citations: 13     Fields:    Translation:Humans
    69. Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol. 2016 09; 240(1):84-95. PMID: 27287813.
      Citations: 17     Fields:    Translation:HumansCells
    70. Liu H, Shen Y, Ning J, Qin J. Sample size calculations for prevalent cohort designs. Stat Methods Med Res. 2017 Feb; 26(1):280-291. PMID: 25091809.
      Citations: 2     Fields:    Translation:Humans
    71. Alatrash G, Thall PF, Valdez BC, Fox PS, Ning J, Garber HR, Janbey S, Worth LL, Popat U, Hosing C, Alousi AM, Kebriaei P, Shpall EJ, Jones RB, de Lima M, Rondon G, Chen J, Champlin RE, Andersson BS. Long-Term Outcomes after Treatment with Clofarabine?┬▒?Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant. 2016 10; 22(10):1792-1800. PMID: 27377901.
      Citations: 6     Fields:    Translation:Humans
    72. Liang L, Jiang Y, Chen JS, Niu N, Piao J, Ning J, Zu Y, Zhang J, Liu J. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases. Hum Pathol. 2016 11; 57:1-6. PMID: 27349304.
      Citations: 20     Fields:    Translation:Humans
    73. Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN, Daver NG. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes. Cancer. 2016 09 15; 122(18):2857-66. PMID: 27244347.
      Citations: 30     Fields:    Translation:Humans
    74. Shen Y, Ning J, Qin J. Nonparametric and semiparametric regression estimation for length-biased survival data. Lifetime Data Anal. 2017 01; 23(1):3-24. PMID: 27086362.
      Citations: 4     Fields:    Translation:Humans
    75. Huang X, Yan F, Ning J, Feng Z, Choi S, Cortes J. A two-stage approach for dynamic prediction of time-to-event distributions. Stat Med. 2016 06 15; 35(13):2167-82. PMID: 26748812.
      Citations: 6     Fields:    Translation:Humans
    76. Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, DiNapoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2016 Jan 10; 34(2):160-8. PMID: 26628470.
      Citations: 86     Fields:    Translation:Humans
    77. Zhou R, Zhu H, Bondy M, Ning J. Semiparametric model for semi-competing risks data with application to breast cancer study. Lifetime Data Anal. 2016 07; 22(3):456-71. PMID: 26340889.
      Citations: 2     Fields:    Translation:Humans
    78. Ning J, Rahbar MH, Choi S, Hong C, Piao J, del Junco DJ, Fox EE, Rahbar E, Holcomb JB. A joint latent class analysis for adjusting survival bias with application to a trauma transfusion study. Stat Med. 2016 Jan 15; 35(1):65-77. PMID: 26256455.
      Citations:    Fields:    Translation:Humans
    79. Ning J, Rahbar MH, Choi S, Piao J, Hong C, Del Junco DJ, Rahbar E, Fox EE, Holcomb JB, Wang MC. Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study. Stat Methods Med Res. 2017 Aug; 26(4):1969-1981. PMID: 26160825.
      Citations: 3     Fields:    Translation:Humans
    80. Shen W, Ning J, Yuan Y. A direct method to evaluate the time-dependent predictive accuracy for biomarkers. Biometrics. 2015 Jun; 71(2):439-49. PMID: 25758584.
      Citations: 6     Fields:    Translation:Humans
    81. Shen W, Ning J, Yuan Y. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance. Stat Med. 2015 Jun 15; 34(13):2104-15. PMID: 25756852.
      Citations:    Fields:    Translation:Humans
    82. Ning J, Qin J, Shen Y. Score Estimating Equations from Embedded Likelihood Functions under Accelerated Failure Time Model. J Am Stat Assoc. 2014 Oct; 109(508):1625-1635. PMID: 25663727.
      Citations: 6     
    83. Tang X, Alatrash G, Ning J, Jakher H, Stafford P, Zope M, Shpall EJ, Jones RB, Champlin RE, Thall PF, Andersson BS. Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time. Biol Blood Marrow Transplant. 2014 Aug; 20(8):1139-44. PMID: 24727332.
      Citations: 10     Fields:    Translation:Humans
    84. Huang X, Ning J, Wahed AS. Optimization of individualized dynamic treatment regimes for recurrent diseases. Stat Med. 2014 Jun 30; 33(14):2363-78. PMID: 24510534.
      Citations: 6     Fields:    Translation:Humans
    85. Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, Hasanein H, Prieto VG. Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol. 2014 Jan; 36(1):74-9. PMID: 23812018.
      Citations: 14     Fields:    Translation:Humans
    86. Ning J, Bandeen-Roche K. Estimation of time-dependent association for bivariate failure times in the presence of a competing risk. Biometrics. 2014 Mar; 70(1):10-20. PMID: 24350628.
      Citations: 2     Fields:    Translation:Humans
    87. Liu S, Ning J. A Bayesian Dose-finding Design for Drug Combination Trials with Delayed Toxicities. Bayesian Anal. 2013 Sep; 8(3):703-722. PMID: 27924182.
      Citations: 4     
    88. Takahashi K, Pemmaraju N, Strati P, Nogueras-Gonzalez G, Ning J, Bueso-Ramos C, Luthra R, Pierce S, Cortes J, Kantarjian H, Garcia-Manero G. Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia. Blood. 2013 Oct 17; 122(16):2807-11; quiz 2920. PMID: 23896412.
      Citations: 17     Fields:    Translation:Humans
    89. Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol. 2013 Sep; 108(3):182-6. PMID: 23804149.
      Citations: 35     Fields:    Translation:Humans
    90. Ning J, Qin J, Asgharian M, Shen Y. Empirical likelihood-based confidence intervals for length-biased data. Stat Med. 2013 Jun 15; 32(13):2278-91. PMID: 23027662.
      Citations: 1     Fields:    Translation:Humans
    91. Huang X, Ning J. Analysis of multi-stage treatments for recurrent diseases. Stat Med. 2012 Oct 30; 31(24):2805-21. PMID: 22826139.
      Citations: 5     Fields:    Translation:Humans
    92. Shen Y, Ning J, Qin J. Likelihood approaches for the invariant density ratio model with biased-sampling data. Biometrika. 2012 Jun; 99(2):363-378. PMID: 23843663.
      Citations: 3     Fields:    
    93. Rate-adaptive bayesian independent component analysis. Electronic Journal of Statistics. 10:3247-3264.
    94. A joint latent class analysis for adjusting survival bias with application to a trauma transfusion study. Statistics in Medicine. 35:65-77.
    95. On the dependence structure of bivariate recurrent event processes. Biometrika. 102:345-358.
    96. Has racial difference in cause-specific death improved in older patients with late-stage breast cancer?. Annals of Oncology. 26:2161-2168.
    97. Semiparametric likelihood inference for left-truncated and right-censored data. Biostatistics. 16:785-798.
    98. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmologica.
    99. Nonparametric estimation of bivariate failure time associations in the presence of a competing risk. Biometrika. 95:221-232.
    100. A hybrid model for combining case-control and cohort studies in systematic reviews of diagnostic tests. Journal of the Royal Statistical Society. Series C: Applied Statistics. 64:469-489.
    101. Biology of Blood and Marrow Transplantation. 22:1792-1800.
    102. Recurrent event frailty models reduced time-varying and other biases in evaluating transfusion protocols for traumatic hemorrhage. Journal of Clinical Epidemiology.
    103. Nonparametric estimation for contamination distribution. Applied Mathematics. 23:175-182.
    104. Semiparametric model for semi-competing risks data with application to breast cancer study. Lifetime Data Analysis.
    105. B7-H4 expression in ovarian serous carcinoma. Human Pathology. 57:1-6.
    106. Score Estimating Equations from Embedded Likelihood Functions Under Accelerated Failure Time Model. Journal of the American Statistical Association. 109:1625-1635.
    107. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance. Statistics in Medicine. 34:2104-2115.
    108. Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP). Annals of Surgical Oncology. 1-7.
    109. A bayesian dose-finding design for drug combination trials with delayed toxicities. Bayesian Analysis. 8:703-722.
    110. Analyzing semi-competing risks data with missing cause of informative terminal event. Statistics in Medicine. 36:738-753.
    111. A joint latent class model for classifying severely hemorrhaging trauma patients Emergency Medicine. BMC Research Notes. 8.
    112. Maximum likelihood estimations and EM algorithms with length-biased data. Journal of the American Statistical Association. 106:1434-1449.
    113. A response-adaptive design of initial therapy for emergency department patients with heart failure. Contemporary Clinical Trials. 52:46-53.
    114. Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma. Ophthalmic Plastic and Reconstructive Surgery.
    115. Sample size calculations for prevalent cohort designs. Statistical Methods in Medical Research. 26:280-291.
    116. Analyzing length-biased data with semiparametric transformation and accelerated failure time models. Journal of the American Statistical Association. 104:1192-1202.
    117. Maximum likelihood estimation for semiparametric density ratio model. International Journal of Biostatistics. 8.
    118. Likelihood approaches for the invariant density ratio model with biased-sampling data. Biometrika. 99:363-378.
    119. Nonparametric and semiparametric regression estimation for length-biased survival data. Lifetime Data Analysis. 1-22.
    120. Semiparametric accelerated failure time model for length-biased data with application to dementia study. Statistica Sinica. 24:313-333.
    121. A direct method to evaluate the time-dependent predictive accuracy for biomarkers. Biometrics. 71:439-449.
    122. A two-stage approach for dynamic prediction of time-to-event distributions. Statistics in Medicine.
    123. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. Journal of Clinical Oncology. 34:160-168.
    124. Non-parametric tests for right-censored data with biased sampling. Journal of the Royal Statistical Society. Series B: Statistical Methodology. 72:609-630.
    NING's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (369)
    Explore
    _
    Co-Authors (162)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _